Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression
ConclusionGlibenclamide protected against aorta transplantation-induced arteriosclerosis by reducing inflammatory factors in vivo and inhibited macrophage migration and MCP-1 production in vitro.
Source: Life Sciences - Category: Biology Source Type: research
More News: Arteriosclerosis | Biology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Genetics | Study | Transplants